Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlo Gilchuk

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
The Journal of Infectious Diseases|August 15, 2018
Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection SurvivorsMatthew S Bramble, Nicole Hoff, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Immunity|July 22, 2018
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinPavlo Gilchuk, Natalia Kuzmina, Philipp A Ilinykh, et al.
Cell Reports|July 2, 2021
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cellMaritza Puray-Chavez, Kyle M LaPak, Travis P Schrank, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
The Journal of Infectious Diseases|August 15, 2018
Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection SurvivorsMatthew S Bramble, Nicole Hoff, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Immunity|July 22, 2018
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinPavlo Gilchuk, Natalia Kuzmina, Philipp A Ilinykh, et al.
Cell Reports|July 2, 2021
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cellMaritza Puray-Chavez, Kyle M LaPak, Travis P Schrank, et al.
Pageof 8